KRAS and BRAF oncogenic mutations are seen in roughly 40% and 10% of CRCs, respectively, and are mutually exclusive in a given CRC (Cancer Genome Atlas Network, 2012; Fearon, 2011). The gene discussed is BRAF; the disease is colorectal carcinoma.